Company Spotlight: Akashi Therapeutics /January 1, 2015
>>>>>
Akashi Therapeutics is a biopharmaceutical company with the mission to develop treatments for Duchenne muscular dystrophy (DMD) and other rare pediatric disease. NeuroInsights spoke with Akashi’s CEO Marc Blaustein about the unique model of the company and their multifaceted approach to treating DMD. Read the full article here.Akashi – Neurotech Insights January 1, 2015